Click for best price
Prilide Antihypertensive Drugs Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Prilide Antihypertensive Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prilide Antihypertensive Drugs. This report contains market size and forecasts of Prilide Antihypertensive Drugs in global, including the following market information:
Global Prilide Antihypertensive Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Prilide Antihypertensive Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Prilide Antihypertensive Drugs companies in 2022 (%)
The global Prilide Antihypertensive Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Captopril Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Prilide Antihypertensive Drugs include Merck, Pfizer, Sanofi, Abbott, Novartis, Changzhou Pharmaceutical, Humanwell Pharmaceutical, Hengcheng Pharmaceutical and Hengwei Pharmaceutical, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Prilide Antihypertensive Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prilide Antihypertensive Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Prilide Antihypertensive Drugs Market Segment Percentages, by Type, 2022 (%)
Captopril
Enalapril
Lisinopril
Fosinopril
Others
Global Prilide Antihypertensive Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Prilide Antihypertensive Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Global Prilide Antihypertensive Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Prilide Antihypertensive Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prilide Antihypertensive Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Prilide Antihypertensive Drugs revenues share in global market, 2022 (%)
Key companies Prilide Antihypertensive Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Prilide Antihypertensive Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Pfizer
Sanofi
Abbott
Novartis
Changzhou Pharmaceutical
Humanwell Pharmaceutical
Hengcheng Pharmaceutical
Hengwei Pharmaceutical
Zhongfu Pharmaceutical
Likang Pharmaceutical
Changjiang Pharmaceutical
Baiyunshan Pharmaceutical
Poly Pharm
Lukang Group
Baili Pharmaceutical
Huahai Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Prilide Antihypertensive Drugs, market overview.
Chapter 2: Global Prilide Antihypertensive Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Prilide Antihypertensive Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Prilide Antihypertensive Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Prilide Antihypertensive Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Prilide Antihypertensive Drugs Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
116 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Prilide Antihypertensive Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prilide Antihypertensive Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prilide Antihypertensive Drugs Overall Market Size
2.1 Global Prilide Antihypertensive Drugs Market Size: 2022 VS 2029
2.2 Global Prilide Antihypertensive Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Prilide Antihypertensive Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Prilide Antihypertensive Drugs Players in Global Market
3.2 Top Global Prilide Antihypertensive Drugs Companies Ranked by Revenue
3.3 Global Prilide Antihypertensive Drugs Revenue by Companies
3.4 Global Prilide Antihypertensive Drugs Sales by Companies
3.5 Global Prilide Antihypertensive Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Prilide Antihypertensive Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Prilide Antihypertensive Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Prilide Antihypertensive Drugs Players in Global Market
3.8.1 List of Global Tier 1 Prilide Antihypertensive Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Prilide Antihypertensive Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Prilide Antihypertensive Drugs Market Size Markets, 2022 & 2029
4.1.2 Captopril
4.1.3 Enalapril
4.1.4 Lisinopril
4.1.5 Fosinopril
4.1.6 Others
4.2 By Type - Global Prilide Antihypertensive Drugs Revenue & Forecasts
4.2.1 By Type - Global Prilide Antihypertensive Drugs Revenue, 2018-2023
4.2.2 By Type - Global Prilide Antihypertensive Drugs Revenue, 2024-2029
4.2.3 By Type - Global Prilide Antihypertensive Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Prilide Antihypertensive Drugs Sales & Forecasts
4.3.1 By Type - Global Prilide Antihypertensive Drugs Sales, 2018-2023
4.3.2 By Type - Global Prilide Antihypertensive Drugs Sales, 2024-2029
4.3.3 By Type - Global Prilide Antihypertensive Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Prilide Antihypertensive Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Prilide Antihypertensive Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application - Global Prilide Antihypertensive Drugs Revenue & Forecasts
5.2.1 By Application - Global Prilide Antihypertensive Drugs Revenue, 2018-2023
5.2.2 By Application - Global Prilide Antihypertensive Drugs Revenue, 2024-2029
5.2.3 By Application - Global Prilide Antihypertensive Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Prilide Antihypertensive Drugs Sales & Forecasts
5.3.1 By Application - Global Prilide Antihypertensive Drugs Sales, 2018-2023
5.3.2 By Application - Global Prilide Antihypertensive Drugs Sales, 2024-2029
5.3.3 By Application - Global Prilide Antihypertensive Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Prilide Antihypertensive Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Prilide Antihypertensive Drugs Market Size, 2022 & 2029
6.2 By Region - Global Prilide Antihypertensive Drugs Revenue & Forecasts
6.2.1 By Region - Global Prilide Antihypertensive Drugs Revenue, 2018-2023
6.2.2 By Region - Global Prilide Antihypertensive Drugs Revenue, 2024-2029
6.2.3 By Region - Global Prilide Antihypertensive Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Prilide Antihypertensive Drugs Sales & Forecasts
6.3.1 By Region - Global Prilide Antihypertensive Drugs Sales, 2018-2023
6.3.2 By Region - Global Prilide Antihypertensive Drugs Sales, 2024-2029
6.3.3 By Region - Global Prilide Antihypertensive Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Prilide Antihypertensive Drugs Revenue, 2018-2029
6.4.2 By Country - North America Prilide Antihypertensive Drugs Sales, 2018-2029
6.4.3 US Prilide Antihypertensive Drugs Market Size, 2018-2029
6.4.4 Canada Prilide Antihypertensive Drugs Market Size, 2018-2029
6.4.5 Mexico Prilide Antihypertensive Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Prilide Antihypertensive Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Prilide Antihypertensive Drugs Sales, 2018-2029
6.5.3 Germany Prilide Antihypertensive Drugs Market Size, 2018-2029
6.5.4 France Prilide Antihypertensive Drugs Market Size, 2018-2029
6.5.5 U.K. Prilide Antihypertensive Drugs Market Size, 2018-2029
6.5.6 Italy Prilide Antihypertensive Drugs Market Size, 2018-2029
6.5.7 Russia Prilide Antihypertensive Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Prilide Antihypertensive Drugs Market Size, 2018-2029
6.5.9 Benelux Prilide Antihypertensive Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Prilide Antihypertensive Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Prilide Antihypertensive Drugs Sales, 2018-2029
6.6.3 China Prilide Antihypertensive Drugs Market Size, 2018-2029
6.6.4 Japan Prilide Antihypertensive Drugs Market Size, 2018-2029
6.6.5 South Korea Prilide Antihypertensive Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Prilide Antihypertensive Drugs Market Size, 2018-2029
6.6.7 India Prilide Antihypertensive Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Prilide Antihypertensive Drugs Revenue, 2018-2029
6.7.2 By Country - South America Prilide Antihypertensive Drugs Sales, 2018-2029
6.7.3 Brazil Prilide Antihypertensive Drugs Market Size, 2018-2029
6.7.4 Argentina Prilide Antihypertensive Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Prilide Antihypertensive Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Prilide Antihypertensive Drugs Sales, 2018-2029
6.8.3 Turkey Prilide Antihypertensive Drugs Market Size, 2018-2029
6.8.4 Israel Prilide Antihypertensive Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Prilide Antihypertensive Drugs Market Size, 2018-2029
6.8.6 UAE Prilide Antihypertensive Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Prilide Antihypertensive Drugs Major Product Offerings
7.1.4 Merck Prilide Antihypertensive Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Prilide Antihypertensive Drugs Major Product Offerings
7.2.4 Pfizer Prilide Antihypertensive Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Prilide Antihypertensive Drugs Major Product Offerings
7.3.4 Sanofi Prilide Antihypertensive Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Sanofi Key News & Latest Developments
7.4 Abbott
7.4.1 Abbott Company Summary
7.4.2 Abbott Business Overview
7.4.3 Abbott Prilide Antihypertensive Drugs Major Product Offerings
7.4.4 Abbott Prilide Antihypertensive Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Abbott Key News & Latest Developments
7.5 Novartis
7.5.1 Novartis Company Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Prilide Antihypertensive Drugs Major Product Offerings
7.5.4 Novartis Prilide Antihypertensive Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Novartis Key News & Latest Developments
7.6 Changzhou Pharmaceutical
7.6.1 Changzhou Pharmaceutical Company Summary
7.6.2 Changzhou Pharmaceutical Business Overview
7.6.3 Changzhou Pharmaceutical Prilide Antihypertensive Drugs Major Product Offerings
7.6.4 Changzhou Pharmaceutical Prilide Antihypertensive Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Changzhou Pharmaceutical Key News & Latest Developments
7.7 Humanwell Pharmaceutical
7.7.1 Humanwell Pharmaceutical Company Summary
7.7.2 Humanwell Pharmaceutical Business Overview
7.7.3 Humanwell Pharmaceutical Prilide Antihypertensive Drugs Major Product Offerings
7.7.4 Humanwell Pharmaceutical Prilide Antihypertensive Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Humanwell Pharmaceutical Key News & Latest Developments
7.8 Hengcheng Pharmaceutical
7.8.1 Hengcheng Pharmaceutical Company Summary
7.8.2 Hengcheng Pharmaceutical Business Overview
7.8.3 Hengcheng Pharmaceutical Prilide Antihypertensive Drugs Major Product Offerings
7.8.4 Hengcheng Pharmaceutical Prilide Antihypertensive Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Hengcheng Pharmaceutical Key News & Latest Developments
7.9 Hengwei Pharmaceutical
7.9.1 Hengwei Pharmaceutical Company Summary
7.9.2 Hengwei Pharmaceutical Business Overview
7.9.3 Hengwei Pharmaceutical Prilide Antihypertensive Drugs Major Product Offerings
7.9.4 Hengwei Pharmaceutical Prilide Antihypertensive Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Hengwei Pharmaceutical Key News & Latest Developments
7.10 Zhongfu Pharmaceutical
7.10.1 Zhongfu Pharmaceutical Company Summary
7.10.2 Zhongfu Pharmaceutical Business Overview
7.10.3 Zhongfu Pharmaceutical Prilide Antihypertensive Drugs Major Product Offerings
7.10.4 Zhongfu Pharmaceutical Prilide Antihypertensive Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Zhongfu Pharmaceutical Key News & Latest Developments
7.11 Likang Pharmaceutical
7.11.1 Likang Pharmaceutical Company Summary
7.11.2 Likang Pharmaceutical Prilide Antihypertensive Drugs Business Overview
7.11.3 Likang Pharmaceutical Prilide Antihypertensive Drugs Major Product Offerings
7.11.4 Likang Pharmaceutical Prilide Antihypertensive Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Likang Pharmaceutical Key News & Latest Developments
7.12 Changjiang Pharmaceutical
7.12.1 Changjiang Pharmaceutical Company Summary
7.12.2 Changjiang Pharmaceutical Prilide Antihypertensive Drugs Business Overview
7.12.3 Changjiang Pharmaceutical Prilide Antihypertensive Drugs Major Product Offerings
7.12.4 Changjiang Pharmaceutical Prilide Antihypertensive Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Changjiang Pharmaceutical Key News & Latest Developments
7.13 Baiyunshan Pharmaceutical
7.13.1 Baiyunshan Pharmaceutical Company Summary
7.13.2 Baiyunshan Pharmaceutical Prilide Antihypertensive Drugs Business Overview
7.13.3 Baiyunshan Pharmaceutical Prilide Antihypertensive Drugs Major Product Offerings
7.13.4 Baiyunshan Pharmaceutical Prilide Antihypertensive Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Baiyunshan Pharmaceutical Key News & Latest Developments
7.14 Poly Pharm
7.14.1 Poly Pharm Company Summary
7.14.2 Poly Pharm Business Overview
7.14.3 Poly Pharm Prilide Antihypertensive Drugs Major Product Offerings
7.14.4 Poly Pharm Prilide Antihypertensive Drugs Sales and Revenue in Global (2018-2023)
7.14.5 Poly Pharm Key News & Latest Developments
7.15 Lukang Group
7.15.1 Lukang Group Company Summary
7.15.2 Lukang Group Business Overview
7.15.3 Lukang Group Prilide Antihypertensive Drugs Major Product Offerings
7.15.4 Lukang Group Prilide Antihypertensive Drugs Sales and Revenue in Global (2018-2023)
7.15.5 Lukang Group Key News & Latest Developments
7.16 Baili Pharmaceutical
7.16.1 Baili Pharmaceutical Company Summary
7.16.2 Baili Pharmaceutical Business Overview
7.16.3 Baili Pharmaceutical Prilide Antihypertensive Drugs Major Product Offerings
7.16.4 Baili Pharmaceutical Prilide Antihypertensive Drugs Sales and Revenue in Global (2018-2023)
7.16.5 Baili Pharmaceutical Key News & Latest Developments
7.17 Huahai Pharmaceutical
7.17.1 Huahai Pharmaceutical Company Summary
7.17.2 Huahai Pharmaceutical Business Overview
7.17.3 Huahai Pharmaceutical Prilide Antihypertensive Drugs Major Product Offerings
7.17.4 Huahai Pharmaceutical Prilide Antihypertensive Drugs Sales and Revenue in Global (2018-2023)
7.17.5 Huahai Pharmaceutical Key News & Latest Developments
8 Global Prilide Antihypertensive Drugs Production Capacity, Analysis
8.1 Global Prilide Antihypertensive Drugs Production Capacity, 2018-2029
8.2 Prilide Antihypertensive Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Prilide Antihypertensive Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Prilide Antihypertensive Drugs Supply Chain Analysis
10.1 Prilide Antihypertensive Drugs Industry Value Chain
10.2 Prilide Antihypertensive Drugs Upstream Market
10.3 Prilide Antihypertensive Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Prilide Antihypertensive Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Prilide Antihypertensive Drugs in Global Market
Table 2. Top Prilide Antihypertensive Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Prilide Antihypertensive Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Prilide Antihypertensive Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Prilide Antihypertensive Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Prilide Antihypertensive Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Prilide Antihypertensive Drugs Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Prilide Antihypertensive Drugs Product Type
Table 9. List of Global Tier 1 Prilide Antihypertensive Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prilide Antihypertensive Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Prilide Antihypertensive Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Prilide Antihypertensive Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Prilide Antihypertensive Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Prilide Antihypertensive Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Prilide Antihypertensive Drugs Sales (K Units), 2024-2029
Table 16. By Application ? Global Prilide Antihypertensive Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Prilide Antihypertensive Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Prilide Antihypertensive Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Prilide Antihypertensive Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Prilide Antihypertensive Drugs Sales (K Units), 2024-2029
Table 21. By Region ? Global Prilide Antihypertensive Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Prilide Antihypertensive Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Prilide Antihypertensive Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Prilide Antihypertensive Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Prilide Antihypertensive Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Prilide Antihypertensive Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Prilide Antihypertensive Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Prilide Antihypertensive Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Prilide Antihypertensive Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Prilide Antihypertensive Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Prilide Antihypertensive Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Prilide Antihypertensive Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Prilide Antihypertensive Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Prilide Antihypertensive Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Prilide Antihypertensive Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Prilide Antihypertensive Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Prilide Antihypertensive Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Prilide Antihypertensive Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Prilide Antihypertensive Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Prilide Antihypertensive Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Prilide Antihypertensive Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Prilide Antihypertensive Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Prilide Antihypertensive Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Prilide Antihypertensive Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Prilide Antihypertensive Drugs Sales, (K Units), 2024-2029
Table 46. Merck Company Summary
Table 47. Merck Prilide Antihypertensive Drugs Product Offerings
Table 48. Merck Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Merck Key News & Latest Developments
Table 50. Pfizer Company Summary
Table 51. Pfizer Prilide Antihypertensive Drugs Product Offerings
Table 52. Pfizer Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Pfizer Key News & Latest Developments
Table 54. Sanofi Company Summary
Table 55. Sanofi Prilide Antihypertensive Drugs Product Offerings
Table 56. Sanofi Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Sanofi Key News & Latest Developments
Table 58. Abbott Company Summary
Table 59. Abbott Prilide Antihypertensive Drugs Product Offerings
Table 60. Abbott Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Abbott Key News & Latest Developments
Table 62. Novartis Company Summary
Table 63. Novartis Prilide Antihypertensive Drugs Product Offerings
Table 64. Novartis Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Novartis Key News & Latest Developments
Table 66. Changzhou Pharmaceutical Company Summary
Table 67. Changzhou Pharmaceutical Prilide Antihypertensive Drugs Product Offerings
Table 68. Changzhou Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Changzhou Pharmaceutical Key News & Latest Developments
Table 70. Humanwell Pharmaceutical Company Summary
Table 71. Humanwell Pharmaceutical Prilide Antihypertensive Drugs Product Offerings
Table 72. Humanwell Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Humanwell Pharmaceutical Key News & Latest Developments
Table 74. Hengcheng Pharmaceutical Company Summary
Table 75. Hengcheng Pharmaceutical Prilide Antihypertensive Drugs Product Offerings
Table 76. Hengcheng Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Hengcheng Pharmaceutical Key News & Latest Developments
Table 78. Hengwei Pharmaceutical Company Summary
Table 79. Hengwei Pharmaceutical Prilide Antihypertensive Drugs Product Offerings
Table 80. Hengwei Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Hengwei Pharmaceutical Key News & Latest Developments
Table 82. Zhongfu Pharmaceutical Company Summary
Table 83. Zhongfu Pharmaceutical Prilide Antihypertensive Drugs Product Offerings
Table 84. Zhongfu Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Zhongfu Pharmaceutical Key News & Latest Developments
Table 86. Likang Pharmaceutical Company Summary
Table 87. Likang Pharmaceutical Prilide Antihypertensive Drugs Product Offerings
Table 88. Likang Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Likang Pharmaceutical Key News & Latest Developments
Table 90. Changjiang Pharmaceutical Company Summary
Table 91. Changjiang Pharmaceutical Prilide Antihypertensive Drugs Product Offerings
Table 92. Changjiang Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Changjiang Pharmaceutical Key News & Latest Developments
Table 94. Baiyunshan Pharmaceutical Company Summary
Table 95. Baiyunshan Pharmaceutical Prilide Antihypertensive Drugs Product Offerings
Table 96. Baiyunshan Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Baiyunshan Pharmaceutical Key News & Latest Developments
Table 98. Poly Pharm Company Summary
Table 99. Poly Pharm Prilide Antihypertensive Drugs Product Offerings
Table 100. Poly Pharm Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Poly Pharm Key News & Latest Developments
Table 102. Lukang Group Company Summary
Table 103. Lukang Group Prilide Antihypertensive Drugs Product Offerings
Table 104. Lukang Group Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. Lukang Group Key News & Latest Developments
Table 106. Baili Pharmaceutical Company Summary
Table 107. Baili Pharmaceutical Prilide Antihypertensive Drugs Product Offerings
Table 108. Baili Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 109. Baili Pharmaceutical Key News & Latest Developments
Table 110. Huahai Pharmaceutical Company Summary
Table 111. Huahai Pharmaceutical Prilide Antihypertensive Drugs Product Offerings
Table 112. Huahai Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 113. Huahai Pharmaceutical Key News & Latest Developments
Table 114. Prilide Antihypertensive Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 115. Global Prilide Antihypertensive Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 116. Global Prilide Antihypertensive Drugs Production by Region, 2018-2023 (K Units)
Table 117. Global Prilide Antihypertensive Drugs Production by Region, 2024-2029 (K Units)
Table 118. Prilide Antihypertensive Drugs Market Opportunities & Trends in Global Market
Table 119. Prilide Antihypertensive Drugs Market Drivers in Global Market
Table 120. Prilide Antihypertensive Drugs Market Restraints in Global Market
Table 121. Prilide Antihypertensive Drugs Raw Materials
Table 122. Prilide Antihypertensive Drugs Raw Materials Suppliers in Global Market
Table 123. Typical Prilide Antihypertensive Drugs Downstream
Table 124. Prilide Antihypertensive Drugs Downstream Clients in Global Market
Table 125. Prilide Antihypertensive Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Prilide Antihypertensive Drugs Segment by Type in 2022
Figure 2. Prilide Antihypertensive Drugs Segment by Application in 2022
Figure 3. Global Prilide Antihypertensive Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Prilide Antihypertensive Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Prilide Antihypertensive Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Prilide Antihypertensive Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Prilide Antihypertensive Drugs Revenue in 2022
Figure 9. By Type - Global Prilide Antihypertensive Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Prilide Antihypertensive Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Prilide Antihypertensive Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Prilide Antihypertensive Drugs Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Prilide Antihypertensive Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Prilide Antihypertensive Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Prilide Antihypertensive Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Prilide Antihypertensive Drugs Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Prilide Antihypertensive Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Prilide Antihypertensive Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Prilide Antihypertensive Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Prilide Antihypertensive Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Prilide Antihypertensive Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Prilide Antihypertensive Drugs Sales Market Share, 2018-2029
Figure 23. US Prilide Antihypertensive Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Prilide Antihypertensive Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Prilide Antihypertensive Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Prilide Antihypertensive Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Prilide Antihypertensive Drugs Sales Market Share, 2018-2029
Figure 28. Germany Prilide Antihypertensive Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Prilide Antihypertensive Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Prilide Antihypertensive Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Prilide Antihypertensive Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Prilide Antihypertensive Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Prilide Antihypertensive Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Prilide Antihypertensive Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Prilide Antihypertensive Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Prilide Antihypertensive Drugs Sales Market Share, 2018-2029
Figure 37. China Prilide Antihypertensive Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Prilide Antihypertensive Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Prilide Antihypertensive Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Prilide Antihypertensive Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Prilide Antihypertensive Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Prilide Antihypertensive Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Prilide Antihypertensive Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Prilide Antihypertensive Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Prilide Antihypertensive Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Prilide Antihypertensive Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Prilide Antihypertensive Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Prilide Antihypertensive Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Prilide Antihypertensive Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Prilide Antihypertensive Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Prilide Antihypertensive Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Prilide Antihypertensive Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Prilide Antihypertensive Drugs by Region, 2022 VS 2029
Figure 54. Prilide Antihypertensive Drugs Industry Value Chain
Figure 55. Marketing Channels
